ReviewAdvances in experimental medicine and biology2026
Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Engineering proteins that can switch between states is of strong interest to biotechnology. These include multi-state transcription factors, membrane receptors, kinases, and synthetic molecular logic gates. While traditional directed evolution approaches excel at optimizing steady-state protein functionalities, they require substantial adaptation to treat transitions in states of proteins. This chapter describes how the emerging regulatory logic of autonomous biological oscillators can be used to impose time-varying selection pressure for evolving switchable proteins. We first review the challenges of evolving switchable proteins and examine past strategies, including fluorescence-activated cell sorting (FACS) screens, alternating chemical selection and counterselection methods, and phage display techniques. We then compare these with "optovolution," an approach recently developed by our lab, which couples a protein's activity to host cell cycle progression and leverages programmable light inputs to drive continuous evolution of proteins. To this end, we explain the design principles underlying the use of an autonomous oscillator for evolution and how it promotes selection for both "on" and "off" states, as well as switching between them. In a direct comparison with a conventional directed evolution method, we elucidate how optovolution proves more reliable by avoiding evolutionary routes that hinder counterselection. In conclusion we discuss how optovolution opens new avenues for creating proteins with complex logic and dynamic control, complementing latest advances in computational protein design.
Indexed as
Identifiers
42782445What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.